Want to see IMA full AI Analyst Report?
ImageneBio (IMA) Stock Statistics & Valuation Metrics
Total Valuation
ImageneBio has a market cap or net worth of $46.60M. The enterprise value is -$36.33M.
- Market Cap
- $46.60M
- Enterprise Value
- -$36.33M
Share Statistics
ImageneBio has 11,351,456 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 11,351,456
- Owned by Insiders
- 35.80%
- Owned by Institutions
- 9.89%
Financial Efficiency
ImageneBio’s return on equity (ROE) is -0.34 and return on invested capital (ROIC) is -33.39%.
- Return on Equity (ROE)
- -0.34
- Return on Assets (ROA)
- -0.30
- Return on Invested Capital (ROIC)
- -33.39%
- Return on Capital Employed (ROCE)
- -0.34
- Revenue Per Employee
- 44.44K
- Profits Per Employee
- -2.52M
- Employee Count
- 18
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of ImageneBio is -0.79. ImageneBio’s PEG ratio is -0.00.
- PE Ratio
- -0.79
- PS Ratio
- 0.00
- PB Ratio
- 0.47
- Price to FCF
- -0.81
- Price to Operating Cash Flow
- -1.15
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, ImageneBio had revenue of 800.00K and earned -45.35M in profits. Earnings per share was -9.64.
- Revenue
- 800.00K
- Gross Profit
- -233.00K
- Operating Income
- -48.45M
- Pretax Income
- -45.70M
- Net Income
- -45.35M
- EBITDA
- -44.67M
- Earnings Per Share (EPS)
- -9.64
Cash Flow
In the last 12 months, operating cash flow was -57.73M and capital expenditures 0, giving a free cash flow of -57.73M billion.
- Operating Cash Flow
- -57.73M
- Free Cash Flow
- -57.73M
- Free Cash Flow per Share
- -3.57
Dividends & Yields
ImageneBio pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -123.90%
- Earnings Yield
- -79.11%
Stock Price Statistics
- Beta
- 0.99
- 52-Week Price Change
- -51.07%
- 50-Day Moving Average
- 4.52
- 200-Day Moving Average
- 5.53
- Relative Strength Index (RSI)
- 42.59
- Average Volume (3m)
- 13.12K
Important Dates
ImageneBio upcoming earnings date is ―, Before Open (Confirmed).
- Last Earnings Date
- Aug 05, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
ImageneBio as a current ratio of 12.49, with Debt / Equity ratio of 7.51%
- Current Ratio
- 12.49
- Quick Ratio
- 12.49
- Debt to Market Cap
- 0.19
- Net Debt to EBITDA
- 0.56
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, ImageneBio has paid -350.00K in taxes.
- Income Tax
- -350.00K
- Effective Tax Rate
- 0.01
Enterprise Valuation
ImageneBio EV to EBITDA ratio is 0.87, with an EV/FCF ratio of 0.80.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.87
- EV to Free Cash Flow
- 0.80
- EV to Operating Cash Flow
- 0.80
Balance Sheet
ImageneBio has $136.15M in cash and marketable securities with $1.91M in debt, giving a net cash position of $134.24M billion.
- Cash & Marketable Securities
- $136.15M
- Total Debt
- $1.91M
- Net Cash
- $134.24M
- Net Cash Per Share
- $11.83
- Tangible Book Value Per Share
- $8.79
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for ImageneBio is $28.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $28.00
- Price Target Upside
- 582.10% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 31.98%
Scores
- Smart Score
- 3
- AI Score
- 45
